{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:51Z","timestamp":1761518811738},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1053\/j.seminoncol.2003.08.021","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"776-788","source":"Crossref","is-referenced-by-count":22,"title":["Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy"],"prefix":"10.1053","volume":"30","author":[{"given":"Rowan T","family":"Chlebowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung A","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nananda F","family":"Col","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2003.08.021_BIB1","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2002.20.24.4611","article-title":"Adjuvant therapy for premenopausal women with breast cancer","volume":"20","author":"Pritchard","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB2","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1200\/JCO.2002.06.617","article-title":"A rose is no longer a rose","volume":"20","author":"Henderson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","article-title":"Aromatase inhibitors in the treatment and prevention of breast cancer","volume":"19","author":"Goss","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomized trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/107327480200900603","article-title":"Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer","volume":"9","author":"Minton","year":"2002","journal-title":"Cancer Control"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","article-title":"Factors influencing the effect of age on prognosis in breast cancers","volume":"320","author":"Kroman","year":"2000","journal-title":"Br Med J"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB9","first-page":"3119","article-title":"American Society of Clinical Oncology Technology Assessment","volume":"20","author":"Winer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB11","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.1999.17.8.2365","article-title":"Risk of menopause during the first year after breast cancer diagnosis","volume":"17","author":"Goodwin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB12","first-page":"141","article-title":"Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) in the adjuvant treatment of node positive breast cancer (BC) patients","volume":"21","author":"Nabholtz","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/oxfordjournals.jncimonographs.a003459","article-title":"Adjuvant therapy for very young women with breast cancer","volume":"30","author":"Goldhirsch","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jnci\/92.11.903","article-title":"Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer","volume":"92","author":"Klijn","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB15","first-page":"359","article-title":"The ZIPP trial of adjuvant zoladex in premenopausal patients with early breast cancer","volume":"19","author":"Houghton","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB16","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1200\/JCO.2002.05.042","article-title":"Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer","volume":"20","author":"Jonat","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB17","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2002.09.112","article-title":"Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil","volume":"20","author":"Jakesz","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB18","article-title":"Chemohormonal therapy in premenopausal node-positive, receptor-positive breast cancer","volume":"15","author":"Davidson","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJM200007203430307","article-title":"Reducing the risk of breast cancer","volume":"343","author":"Chlebowski","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB20","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2002.06.029","article-title":"American Society of Clinical Oncology Technology Assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition","volume":"20","author":"Chlebowski","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB25","first-page":"246","article-title":"Estrogen as a cause of human cancer","volume":"48","author":"Henderson","year":"1988","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00004","article-title":"Elevated serum estradiol and testosterone concentrations are associated with a high risk of breast cancer","volume":"130","author":"Cauley","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB29","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Estrogen plus progestin influence on breast cancer and mammography in healthy postmenopausal women","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1470-2045(02)00732-5","article-title":"Hormone-replacement therapy and breast cancer","volume":"3","author":"Marsden","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB32","first-page":"1017","article-title":"Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer","volume":"166","author":"Pritchard","year":"2002","journal-title":"Can Med Assoc J"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1200\/JCO.1999.17.1.130","article-title":"Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer","volume":"17","author":"Chlebowski","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB34","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.288.1.58","article-title":"Heart and Estrogen\/Progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB35","unstructured":"US Preventive Services Task Force: Recommendation and rationale. Hormone replacement therapy for primary prevention of chronic conditions. http:\/\/www.ahcpr.gov\/clinic\/3rduspstf\/hrt\/httrr.htm"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB36","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/ejso.1998.0617","article-title":"A case-control study of hormone replacement therapy after primary surgical breast cancer treatment","volume":"25","author":"Ursic-Vrscaj","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB38","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.1999.17.5.1482","article-title":"Estrogen replacement therapy after localized breast cancer","volume":"17","author":"Vassilopoulou-Sellin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality","volume":"93","author":"O\u2019Meara","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000055319","article-title":"Hormone replacement therapy after treatment of breast cancer","volume":"60","author":"Beckmann","year":"2001","journal-title":"Oncology"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB41","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5694\/j.1326-5377.2002.tb04835.x","article-title":"Hormone replacement therapy after a diagnosis of breast cancer","volume":"177","author":"Durna","year":"2002","journal-title":"Med J Aust"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB42","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2001.19.8.2357","article-title":"Hormone replacement therapy after breast cancer","volume":"19","author":"Col","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/713605234","article-title":"Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer","volume":"5","author":"Dew","year":"2002","journal-title":"Climacteric"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0885-3924(00)00142-1","article-title":"Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer","volume":"19","author":"Stein","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB45","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.1999.17.8.2371","article-title":"Predictors of sexual health in women after a breast cancer diagnosis","volume":"17","author":"Ganz","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB46","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(02)11774-0","article-title":"Hot flushes","volume":"360","author":"Stearns","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/77.11.1207","article-title":"Pathophysiology and treatment of hot flashes","volume":"77","author":"Shanafelt","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB48","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.4065\/77.11.1155","article-title":"Hot flashes","volume":"77","author":"Fitzpatrick","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB49","series-title":"Principles and Practice of Supportive Oncology","first-page":"1","article-title":"Evaluation and management of hot flashes in cancer patients","author":"Jacolsen","year":"2002"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB50","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1188\/02.ONF.E16-E25","article-title":"Hot flashes and related outcomes in breast cancer survivors and matched comparison women","volume":"29","author":"Carpenter","year":"2002","journal-title":"Oncol Nurs Forum"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB51","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1200\/JCO.2001.19.23.4280","article-title":"Methodologic lessons learned from hot flash studies","volume":"19","author":"Sloan","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB52","series-title":"Oral oestrogen replacement therapy versus placebo for hot flashes. Cochrane Database Syst Rev CD002978","author":"MacLennan","year":"2001"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/annonc\/mdf151","article-title":"Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients","volume":"13","author":"Bertelli","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes","volume":"331","author":"Loprinzi","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0029-7844(99)00266-5","article-title":"Transdermal progesterone cream for vasomotor symptoms and menopausal bone loss","volume":"94","author":"Leonetti","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<483::AID-CNCR9>3.0.CO;2-L","article-title":"A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer","volume":"77","author":"Cobau","year":"1991","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB58","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/1097-0142(195407)7:4<758::AID-CNCR2820070415>3.0.CO;2-L","article-title":"Hormonal therapy in cancer of the breast","volume":"7","author":"Segahoff","year":"1954","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB59","first-page":"159","article-title":"Premarin in the management of metastastic breast carcinoma in postmenopausal patients","volume":"5","author":"Smith","year":"1979","journal-title":"Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(96)70378-2","article-title":"A one-year multicenter of efficacy and safety of continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging","volume":"174","author":"Henriksson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB61","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1210\/jc.86.6.2757","article-title":"Serum lipid profile improved by ultra-low doses of 17beta-estradiol in elderly women","volume":"86","author":"Naessen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB62","first-page":"241","article-title":"Double-blind crossover trial of Replens versus KY jelly for treating vaginal dryness and dysparunia in breast cancer survivors","volume":"15","author":"Law","year":"1996","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes","volume":"12","author":"Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB64","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000292736","article-title":"Veralipride for hot flashes during gonadotropin releasing hormone agonist treatment","volume":"34","author":"Vercellini","year":"1992","journal-title":"Gynecol Obstet Invest"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB66","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1185\/03007998409110119","article-title":"Veralipride versus conjugated oestrogens","volume":"8","author":"Wesel","year":"1984","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB67","first-page":"795","article-title":"Nonhormonal treatment of the menopausal syndrome","volume":"33","author":"Lebherz","year":"1969","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB68","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms","volume":"137","author":"Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.308.6927.501","article-title":"Effect of oral gamolenic acid from evening primrose oil on menopausal flushing","volume":"308","author":"Chenoy","year":"1994","journal-title":"BMJ"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/jwh.1998.7.525","article-title":"A review of the effectiveness of Cimifuga racemosa (black cohosh) for the symptoms of menopause","volume":"7","author":"Lieberman","year":"1998","journal-title":"J Women Health Initiat"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB71","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ajhp\/56.14.1400","article-title":"\u201cBlack cohosh\u201d","volume":"56","author":"Pepping","year":"1999","journal-title":"Am J Health Systems Pharm"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB72","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1200\/JCO.2001.19.10.2739","article-title":"Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer","volume":"19","author":"Jacobson","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB73","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.2000.18.5.1068","article-title":"Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors","volume":"18","author":"Quella","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB74","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1200\/JCO.20.6.1449","article-title":"Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer","volume":"20","author":"Van Patten","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB75","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0015-0282(97)00397-X","article-title":"Does dong quai have estrogenic effects in postmenopausal women?","volume":"68","author":"Hirata","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB76","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamin E for hot flashes in breast cancer survivors","volume":"16","author":"Barton","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB77","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB78","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB79","first-page":"1463","article-title":"Pilot evaluations of newer antidepressants for hot flashes","volume":"21","author":"Barton","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB80","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4088\/JCP.v63n0414","article-title":"Prevalence of sexual dysfunction among newer antidepressants","volume":"63","author":"Clayton","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB81","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/77.11.1159","article-title":"Pilot evaluation of gabapentin for treating hot flashes","volume":"77","author":"Loprinzi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5122(98)00004-8","article-title":"Physical exercise and vasomotor symptoms in postmenopausal women","volume":"29","author":"Ivarsson","year":"1998","journal-title":"Maturitas"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB83","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/92.13.1054","article-title":"Managing menopausal symptoms in breast cancer survivors","volume":"92","author":"Ganz","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5694\/j.1326-5377.2002.tb04763.x","article-title":"Treatment for hot flashes in women receiving tamoxifen","volume":"177","author":"Bydder","year":"2002","journal-title":"Med J Aust"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1300\/J077v20n03_03","article-title":"Women like me","volume":"20","author":"Bond","year":"2002","journal-title":"J Psychosoc Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB86","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02599636","article-title":"The framing effect of relative and absolute risk","volume":"8","author":"Malenka","year":"1993","journal-title":"JGIM"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9343(92)90100-P","article-title":"Absolutely relative","volume":"92","author":"Forrow","year":"1992","journal-title":"Am J Med"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB88","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.309.6957.761","article-title":"Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration","volume":"309","author":"Bucher","year":"1994","journal-title":"BMJ"},{"key":"10.1053\/j.seminoncol.2003.08.021_BIB89","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0272989X9501500208","article-title":"Communicating the benefits of chronic preventive therapy","volume":"15","author":"Hux","year":"1995","journal-title":"Med Decis Mak"},{"key":"10.1053\/j.seminoncol.2003.08.021_FR21","series-title":"Comprehensive Management of Menopause","first-page":"5","author":"Lorrain","year":"1994"},{"key":"10.1053\/j.seminoncol.2003.08.021_FR22","series-title":"Clinical Gynecologic Endocrinology and Infertility","first-page":"282","author":"Speroff","year":"1999"},{"key":"10.1053\/j.seminoncol.2003.08.021_FR23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.08.021_FR24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000048088","article-title":"Biological effects of hormone replacement therapy in relation to serum estradiol levels","volume":"56","author":"Yasui","year":"2001","journal-title":"Horm Res"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403004718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403004718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T17:01:44Z","timestamp":1586538104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775403004718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0093775403004718"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2003.08.021","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}